ContraFect
CFRX
$0.05000
Share price
-27.95%
Change (1 day)
-97.77%
Change (1 year)
Categories
ContraFect (CFRX) - Total assets
Total assets on the balance sheet as of September 2023 : $9.12 M
According to ContraFect's latest financial reports the company's total assets are $9.12 M. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
ContraFect - Total assets on balance sheet (from 2013 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $20.67 M | -69.03% |
| 2021-12-31 | $66.76 M | 30.61% |
| 2020-12-31 | $51.11 M | 46.01% |
| 2019-12-31 | $35 M | 6.5% |
| 2018-12-31 | $32.87 M | -34.5% |
| 2017-12-31 | $50.18 M | 33.4% |
| 2016-12-31 | $37.62 M | 4.92% |
| 2015-12-31 | $35.86 M | 19.32% |
| 2014-12-31 | $30.05 M | 210.35% |
| 2013-12-31 | $9.68 M | -26.67% |
| 2012-12-31 | $13.2 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Viking Therapeutics
VKTX | $0.96 B | 10,502.94% | 🇺🇸 USA |
 Recro Pharma
REPH | N/A | N/A | 🇺🇸 USA |
 Prometheus Biosciences RXDX | $0.75 B | 8,211.39% | 🇺🇸 USA |